FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...

TCS and Pearson partner to accelerate AI-powered learning for global industries

Pearson (FTSE: PSON.L), the world's lifelong learning company, and Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a global leader in IT services and consulting, have announced a multi-year ...

Pearson India, Infinity Learn launch AI test series for JEE, NEET

Global education company Pearson has partnered with edtech platform Infinity Learn, the digital learning arm of Sri Chaitanya Group, to launch an AI-powered Competitive Exam Test Series aimed at ...